User:FatemehNovin/sandbox

Seven-year-old girl, Turkey, 2012

A seven-year-old girl was brought to a clinic by her mother with the complaint of masturbatory behavior characterized by "flexing the legs and rubbing on objects." The mother claimed that this behavior began when the child was three-years-old. In the past year, the girl began exhibiting this behavior in a crowded environment and the masturbation continued to increase in the 6 months prior to the clinic visit. The girl would repeatedly masturbate 15-20 times a day. She was taken out of school because she would continue this conduct during class-time.

The girl was initially seeing a pediatrician but was then referred to a neurologist due to no observed abnormalities in her laboratory values and physical examination. The mental evaluation showed that she was developing and acting properly for her age aside from exhibiting masturbatory behavior during observation. There were no signs or symptoms of mental disorders nor was there any family history of psychiatric diseases or disorders. Based on these observations, test results, and family history, the girl was diagnosed with excessive childhood masturbation.

The family was recommended behavior suggestions. A psychiatrist was also consulted and prescribed risperidone 1 mg/day. After two weeks of this regimen, there was no observed decrease in the behavior. The strength was then increased to 1.5 mg/day. After one week the family reported that the behavior continued with very little change. The risperidone was discontinued because it made the girl excessively sleepy.

The girl was then prescribed aripriprazole oral solution 2.5 mg/day because she "experienced marked sedation with partial benefit from risperidone treatment." After ten days, she was exhibiting a reduction in the masturbatory behavior. The strength of the medication was increased to 4 mg/day as she was still masturbating 5-6 times daily. At the three month follow-up visit she was reported to have ceased all masturbatory behavior. Her medication was reduced by tapering the dose and there were no reoccurrences in the follow-ups after stopping the medication.